Cargando…

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience

AIM: To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary care setting. METHODS: We performed a retrospective analysis of treatment outcomes among treatment-naïve and treatment-experienced patients receiving a minimum 3 mo tenofovir therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovett, Grace C, Nguyen, Tin, Iser, David M, Holmes, Jacinta A, Chen, Robert, Demediuk, Barbara, Shaw, Gideon, Bell, Sally J, Desmond, Paul V, Thompson, Alexander J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220271/ https://www.ncbi.nlm.nih.gov/pubmed/28105258 http://dx.doi.org/10.4254/wjh.v9.i1.48

Ejemplares similares

‘Teach-back’ is a simple communication tool that improves disease knowledge in people with chronic hepatitis B – a pilot randomized controlled study
por: Tran, Sophie, et al.
Publicado: (2019)

Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
por: Michienzi, Sarah M, et al.
Publicado: (2021)

Real-world treatment attrition rates in advanced esophagogastric cancer
por: Tsang, Erica S, et al.
Publicado: (2020)

Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection
por: Chen Yi Mei, Swee Lin G., et al.
Publicado: (2017)

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
por: Su, Pei-Yuan, et al.
Publicado: (2021)

The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience
por: Winter, Rebecca J., et al.
Publicado: (2022)

Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data
por: Hervás-Morón, Asunción, et al.
Publicado: (2022)

Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients
por: Lai, Rui-Min, et al.
Publicado: (2023)

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease
por: Hoffmann, Peter, et al.
Publicado: (2019)

Clinical performance evaluation of O-Ring Halcyon Linac: A real-world study
por: Wang, Guang-Yu, et al.
Publicado: (2022)

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
por: Pulusu, Samba Siva Reddy, et al.
Publicado: (2020)

High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study
por: Yee, Jasmine, et al.
Publicado: (2021)

Christine Guthrie: Splicing genetics and mentorship into the RNA world
por: Tollervey, David, et al.
Publicado: (2022)

Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
por: Li, Lanqing, et al.
Publicado: (2023)

Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China
por: Yan, Yun-Wei, et al.
Publicado: (2023)

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety
por: Latt, Nyan L, et al.
Publicado: (2017)

Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
por: Wang, Dong-Xu, et al.
Publicado: (2020)

Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
por: Li, Daneng, et al.
Publicado: (2023)

Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide
por: Maggiolo, Franco, et al.
Publicado: (2022)

Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV
por: Rolle, Charlotte-Paige, et al.
Publicado: (2021)

Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions
por: Fujii, Hideki, et al.
Publicado: (2017)

Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective
por: Li, James Weiquan, et al.
Publicado: (2017)

Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients
por: Low, Elizabeth SL, et al.
Publicado: (2021)

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
por: Isaksson, Jenny, et al.
Publicado: (2021)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis
por: Benson III, Al B, et al.
Publicado: (2017)

Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort
por: Steinebrunner, Niels, et al.
Publicado: (2018)

Real-world five-year outcomes of FlexyRap(®) cobalt-chromium rapamycin-eluting stents with biodegradable polymer in patients with de-novo coronary artery disease
por: Garg, Nitish, et al.
Publicado: (2023)

Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV‐1‐infected patients: a real‐world study in Japan
por: Kanda, Naoki, et al.
Publicado: (2021)

Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
por: Patwala, Kurvi, et al.
Publicado: (2022)

Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy
por: Chautant, Fiona, et al.
Publicado: (2020)

Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population
por: Lam, Ka-On, et al.
Publicado: (2019)

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
por: Marcellin, Patrick, et al.
Publicado: (2016)

Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B
por: Kim, Young Min, et al.
Publicado: (2018)

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
por: Herta, Toni, et al.
Publicado: (2022)

Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
por: Peng, Wenting, et al.
Publicado: (2023)

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort
por: Clark, Paul J., et al.
Publicado: (2022)

Safety and performance of the EverPro(TM )everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario
por: Trimukhe, Rahul, et al.
Publicado: (2020)

Prediction of lymph node metastasis in early gastric signet-ring cell carcinoma: A real-world retrospective cohort study
por: Yang, Jia-Jia, et al.
Publicado: (2023)

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
por: Emond, Bruno, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_api9cf253cuj66b2neo7pbs4rm